Table 2.
Perinatal outcomes of patients with COVID-19 during pregnancy
| Outcome | Patients with COVID-19 during pregnancy (n = 14) | Patients who developed SARS-CoV-2 neutralized IgM/IgG antibodies after delivery |
|||
|---|---|---|---|---|---|
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | ||
| GA of delivery (weeks), mean (range) | 38 + 3 | 39 | 39 + 1 | 41 + 2 | 39 + 5 |
| Time from disease onset to delivery (days), mean (SD, range) | 5.4 (6.3, 1–21) | 46 | 15 | 2 | 43 |
| PROM | 2 (14.2) | No | No | No | No |
| Foetal distress | 2 (14.2) | No | No | No | No |
| Caesarean section | 12 (85.7) | Yes | Yes | Yes | No |
| Amniotic fluid pollution | 6 (42.8) | No | No | No | No |
| Live birth | 14 (100) | Yes | Yes | Yes | Yes |
| Hospital stay (days), mean (SD, range) | 19 (7.9, 9–9) | 39 | 16 | 10 | 9 |
| Neonate baseline characters | |||||
| Birth weight (g), mean (SD, range) | 3224 (421, 2700–120) | 2700 | 3930 | 4120 | 2900 |
| NICU admission | 7 (50) | Yes | Yes | Yes | No |
| Neonatal asphyxia | 1 (7.1) | No | No | No | No |
| Neonatal jaundice | 5 (35.7) | Yes | Yes | No | No |
| Fever | 1 (7.1) | Yes | No | No | No |
| Anaemia | 1 (7.1) | No | No | No | No |
Data are presented as n (%) unless otherwise indicated. COVID-19, coronavirus disease 2019; GA, gestational age; NICU, neonatal intensive care unit; PROM, premature rupture of membrane; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SD, standard deviation.